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Rapidly Progressive Statin Induced Necrotizing Myopathy
Taha Ashraf, Yusuf Alalwan, Eric Scher, Department of Internal Medicine
Henry Ford Health System, Detroit, Michigan

INTRODUCTION

CASE PRESENTATION

DISCUSSION

• Statins are common lipid lowering agents used worldwide to
reduce cardiovascular mortality. With its ubiquitous use,
physicians need to be aware of its potentially life threatening
myopathies.
• Myopathies vary widely in severity from myalgia’s to life
threatening rhabdomyolysis and necrotizing autoimmune
myopathy

• Chest X-Ray showed no acute abnormality
• EMG demonstrated fibrillations indicative of muscle
irritability. Negative inspiratory force measurements were
reduced
• Urgent muscle biopsy was obtained and he was started on
IVIG and IV methylprednisolone
• Over 5 days, patient came off oxygen, tube feedings and
became able to sit with minimal assistance
• Muscle biopsy demonstrated moderately active necrotizing
myopathy with myofiber necrosis consistent with a statin
induced necrotizing myopathy

• Necrotizing myopathies may be secondary to autoimmune
(NAM) or toxic etiologies. Autoimmune causes are
associated with anti-SRP or anti-HMGCR antibodies, though
one-third are not associated with a specific antibody1
• NAM associated with HMGCR-IgG have a relatively milder
course and its negativity in this case is consistent with its
rapidly progressive sequence
• The largest risk factor is by far, statins, artorvastatin and
simvastatin the common reported2. Of note, Atorvastatin was
recently started, one month prior to symptom onset on our
patient
• As in our patient, EMG demonstrates fibrillations indicative
of muscle irritability and biopsy show fiber necrosis (100%)
and regeneration often confined to perivascular sites in
perimysium2
• Although no randomized clinical trials exist to guide therapy
in NAM, early dual treatment with IVIG and corticosteroids
together is recommended1

CASE PRESENTATION
• A 50 year old male with past medical history of coronary
artery disease and alcoholic liver cirrhosis was admitted from
a subacute rehabilitation facility for symptomatic ascites and
evaluation for liver transplant.
• Notably he had multiple recent admissions for spontaneous
bacterial peritonitis
• He endorsed fatigue and difficulty mobilizing over the past
week, initially attributed to deconditioning from recent
hospital stays

• Extensive serological work-up was negative for other
potential causes

• Over 3 days he developed rapidly progressive proximal
muscle weakness, became bed bound and unable to move his
limbs against gravity. No fevers, muscle tenderness or rash
noted.
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• Lab work remarkable for Creatinine 1.7 mg/dL (resolving AKI
from previous admission), CPK 1281 IU/L.
• No evidence of spontaneous bacterial peritonitis or other
infectious process
• Medication review noted 80mg of Atorvastatin was started 1
month prior which was ceased
• Day 4 patient developed dysphagia requiring a dobhoff. He
became tachypneic with a new 2 L O2 oxygen requirement.

Figure 1: Hematoxylin-eosin–stained section of a vastus lateralis
muscle showing numerous necrotic and regenerating fibers. 1

CONCLUSION
This case highlights a potentially fatal adverse effect of statins, a commonly used drug class by physicians worldwide.
Physicians should be vigilant for significant myopathy when using these medications as swift initiation of treatment particularly in necrotizing
1
forms improve outcomes

